Enrollment and outcomes for Stage2. Trial schedule was similar to... | Download High-Resolution Scientific Diagram
Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 Study | SpringerLink
Safety and immunogenicity of Vi-DT conjugate vaccine among 6-23-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study - eClinicalMedicine
The effect of intravenous iron supplementation on exercise capacity in iron-deficient but not anaemic patients with chronic kidney disease: study design and baseline data for a multicentre prospective double-blind randomised controlled trial
Asenapine for the Acute Treatment of Pediatric Manic or Mixed Episode of Bipolar I Disorder - Journal of the American Academy of Child & Adolescent Psychiatry
<Title (Maximum 255 Characters)>
Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT | Hypertension
Enrollment and outcomes for Stage2. Trial schedule was similar to... | Download High-Resolution Scientific Diagram
A Phase 3, Multicenter, Randomized, Controlled Trial to Evaluate Immune Equivalence and Safety of Multidose and Single-dose Formulations of Vi-DT Typhoid Conjugate Vaccine in Healthy Filipino Individuals 6 Months to 45 Years
Asenapine for the Acute Treatment of Pediatric Manic or Mixed Episode of Bipolar I Disorder - Journal of the American Academy of Child & Adolescent Psychiatry
Multi-strain fermented milk promotes gut microbiota recovery after Helicobacter pylori therapy: a randomised, controlled trial | medRxiv
The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment - ScienceDirect
Frontiers | Safety monitoring in inactivated COVID-19 vaccines by clinical pharmacists from a single center in China
Frontiers | Secukinumab Demonstrates Sustained Efficacy and Safety in a Taiwanese Subpopulation With Active Ankylosing Spondylitis: Four-Year Results From a Phase 3 Study, MEASURE 1
A Phase 3, Multicenter, Randomized, Controlled Trial to Evaluate Immune Equivalence and Safety of Multidose and Single-dose Formulations of Vi-DT Typhoid Conjugate Vaccine in Healthy Filipino Individuals 6 Months to 45 Years
A Phase 3, Multicenter, Randomized, Controlled Trial to Evaluate Immune Equivalence and Safety of Multidose and Single-dose Formulations of Vi-DT Typhoid Conjugate Vaccine in Healthy Filipino Individuals 6 Months to 45 Years
Multi-strain fermented milk promotes gut microbiota recovery after Helicobacter pylori therapy: a randomised, controlled trial | medRxiv
The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment - ScienceDirect
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-c
Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years - Bruce AC Cree, Douglas L Arnold, Robert
